Relationship between delayed menarche and bone density in patients affected by juvenile;Mineralizzazione scheletrica in una popolazione femminile prepubere affetta da artrite idiopatica giovanile

Reumatismo

Volumn 60, Issue 3, 2008, Pages 224-229

  Lurati, Alfredomaria ^a   Cimaz, R ^b   Gattinara, M ^c   Gerloni, V ^c   Teruzzi, B ^c   Salmaso, A ^c   Fantini, F ^c  

^a Ospedale G Fornaroli   (Italy)

^b ICP   (Italy)

^c ISTITUTO ORTOPEDICO GAETANO PINI   (Italy)

Author keywords

JIA; Menarche; Mineralization

Indexed keywords

CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HEMOGLOBIN; METHOTREXATE; PREDNISONE; STEROID;

ADOLESCENT; ARTICLE; BODY HEIGHT; BODY MASS; BONE DENSITY; BONE MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DUAL ENERGY X RAY ABSORPTIOMETRY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GEOMETRY; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LUMBAR SPINE; MENARCHE; MONITORING; PROSPECTIVE STUDY; SCORING SYSTEM;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; ADRENAL CORTEX HORMONES; ARTHRITIS, JUVENILE RHEUMATOID; BONE DENSITY; BONE DISEASES, METABOLIC; CALCIFICATION, PHYSIOLOGIC; CHILD; FEMALE; HUMANS; LUMBAR VERTEBRAE; MENARCHE; METHOTREXATE; PROSPECTIVE STUDIES; PUBERTY, DELAYED;

EID: 57149134963     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Matkovic V, Jelic T, Wardlow G, et al. Timing of peak bone mass in caucasian females and its implication for the prevention of osteoporosis. J Clin lnvest 1994; 93: 799-808.
2. Ott S. Attainment of peak bone mass. J Clin Endocrinot Metab 1990; 71, 5: 1082.
3. Warady B, Lindsley C, Robinson R, et al. Effects of nutritional supplementation on bone mineral status of children with rheumatic diseases receiving corticosteroid therapy. J Rheumatol 1994; 21, 3: 530-5.
4. Henderson C, Lovell D. Nutritionai aspects ofjuvenile rheumatoid arthritis. Rheum Dis Clin North Am 1991; 17, 2: 403-13.
5. Fraser P, Hoch 5, Erlandson D, et al. The timing of menarche in juvenile rheumatoid arthritis. J Adol Health Care 1988; 9: 483-7.
6. Henderson C, Cawkwell G, Specker B, et al. Predictors of total body bone mineral density in non-corticosteroid treated prepubertal children with juvenile rheumatoid arthritis. Arthritis Rheum 1997; 40, 11: 1967-75.
7. Henderson C, Specker B, Sierra R, et al. Total-body bone mineral content in non-corticosteroid treated postpubertal females with juvenile rheumatoid arthritis. Arthritis Rheum 2000; 43: 531-40.
8. Hopp R, Degan J Gallagher J, et al. Estimation of bone mineral density in children with juvenile rheumatoid arthritis. J Rheum 1991; 8: 1235-9.
9. Pepmueller P, Cassidy J, Allen 5, et al. Bone mineralization and bone mineral metabolism in children with juvenile rheumatoid arthritis. Arthritis Rheum 1996; 39, 5: 746-57.
10. Brik R, Keidar Z, Schapira D, et al. Bone mineral density and turnover in children with systemic juvenile chronic arthritis Joumal of Rheumatology 1998; 25: 990-2.
11. Fantini F. Beltrametti P. Gallazzi M, et al. Evaluation by dual-photon absorptiometry of bone mineral loss in rheumatic children on long-term treatment with corticosteroids Cm Exp Rheumatol 1991; 9: 21-8.
12. Bianchi ML, Cimaz R, Galbiati E, et al. Bone mass change during methotrexate tratment in patients with juvenile rheumatoid arthritis Osteoporos mt 1999; 10: 20-5.